Hayes PK, Nasim A., London NJ, et al. In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992-98). J Vasc Surg1999;30: 92-98
2.
D'Addato M., Curt T., Freyrie A., Agus GB, Bertni D., Biasi G.Prevention of early graft infection with rifampicin-bonded gelseal grafts: a multicentre experimental study. Cardiovasc Surg1994;2:254-258
3.
Goeau-Brissonniere O., Mercier F., Nicolas MH, et al. Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft . J Vasc Surg1994;19:739-744
4.
Magnan PE, Seyral P., Raoult D., Branchereau A.In vitro antistaphylococcal activity of collagen-sealed dacron vascular prosthesis bonded with rifampin, vancomycin, or amikacin. Ann Vasc Surg1994;8:243-247
5.
Lachapelle K. , Graham AM, Symes JFAntibacterial activity, antibiotic retention, and infection resistance of a rifampin-impregnated gelatin-sealed Dacron graft . J Vasc Surg1994;19:675-682
6.
Kieffer E., Bahnini A., Koskas F., Ruotolo C., LeVlevec D., Plissonnier D.In situ allograft replacement of infected infrarenal aortic prosthetic grafts: results in forty-three patients. J Vasc Surg1993;17:349-355
7.
Nevelsteen A. , Feryn T., Lacroix H., Suy R., Goffin Y.Experience with cryopreserved arterial allografts in the treatment of prosthetic graft infections . Cardiovasc Surg1998;6: 378-383
